LAVA Therapeutics N.V.

NASDAQ:LVTX

1.26 (USD) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -25.114-41.695-31.658-51.232-20.437-10.991
Depreciation & Amortization 0.4671.2780.7810.6330.6060.294
Deferred Income Tax -0.01-0.279-0.249-0.178-0.0530
Stock Based Compensation 3.2265.0394.1134.4290.6830.218
Change In Working Capital 4.383-2.82734.11312.2865.7080.705
Accounts Receivables 01.589-2.70.774-1.3090.037
Inventory 0000-0.520
Accounts Payables -1.5690.3341.4131.8340.347-0.216
Other Working Capital 5.952-4.7532.710.4527.190.883
Other Non Cash Items -2.496-0.488-3.0571.1430.691-0.192
Operating Cash Flow -19.544-38.9724.043-32.477-12.765-9.775
Investing Activities:
Investments In Property Plant And Equipment -0.023-0.73-0.587-0.866-0.659-0.865
Acquisitions Net 000000
Purchases Of Investments -97.09-90.082-70.877-51.3470-0.034
Sales Maturities Of Investments 109.573.17780.812.84600
Other Investing Activites 0.08809.276-42.6130-0.029
Investing Cash Flow 12.475-17.6359.346-49.367-0.659-0.899
Financing Activities:
Debt Repayment -0.596-0.5710.2680.341.7931.176
Common Stock Issued 00094.18900
Common Stock Repurchased 0000-6.1530
Dividends Paid 000000
Other Financing Activities 0.02700.01556.63117.1760
Financing Cash Flow -0.569-0.5710.283171.37224.1971.334
Other Information:
Effect Of Forex Changes On Cash -1.5781.076-4.208-4.441-1.214-0.491
Net Change In Cash -9.216-56.1029.46485.0869.559-9.83
Cash At End Of Period 35.01544.231100.333103.01919.4298.326